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1. Introduction  
Detection of biological information using magnetoresistance (MR) sensors based on 
multilayered giant MR (GMR), or exchange biased GMR spin valves, operated by the 
magnetic field produced by magnetic nanoparticle sensor agents has been paid considerable 
attention in biomedical sensor technologies (Baselt et al., 1998; Tondra et al., 2000; Rife et al., 
2003; Graham et al., 2004). The main reason for this interest is that MR based biosensors 
provide technical advantages such as high sensitivity, relatively fast and low-volume assay, 
and easy manipulation of the magnetic sensor agents under the externally applied magnetic 
field gradients (Graham et al., 2002; Lagae et al., 2002). These advantages lead to improved 
sensing performance, stimulating the development of functional in-vitro GMR based 
biosensors to obtain biological information and diagnose diseases more accurately in 
healthcare (Megen & Prins, 2005).  
However, all the developed GMR biosensors so far were mostly focused on counting or 
indentifying multiple biomolecules such as a DNA counter and a bead array counter rather 
than single molecular detection (SMD) (Baselt et al., 1998; Miller et al., 2001; Graham et al., 
2003; Li & Wang, 2003; Schepper et al., 2004; Wang et al., 2005; Shen et al., 2005). The main 
physical reason for this technical limitation is that the magnetic susceptibility of a single 
superparamagnetic nanoparticle sensor agent (SPNSA), which can be easily manipulated on 
the sensor surface without any serious agglomeration and easily retrieve magnetic stray 
field, is too small to generate a large enough field for acheiving a reasonably high SNR 
(Singal-to-Noise Ratio). Although superparamagentic microbeads have been attempted to 
obtain a larger stray field for higher SNR for SMD (Graham et al., 2002; Wirix-Speetiens et 
al., 2006), these agents were also revealed to have a technical drawback that they can not 
maintain one to one ratio between the microbead and the biomolecules due to a big 
mismatch in size. Hence, to develop more powerful in-vitro GMR bisoensor system for 
SMD, ferrimagentic nanoparticle (FN) sensor agents, which have a high remnant 
magentization expecting to producing a sufficient stray field for a higher SNR, and a high 
chemical stability as well as a high biocompatibility with living cells or biological entities, 
are currently considered as a feasible sensor agent to label the biomolecules. However, the 
applications of FN to a GMR biosensor agent has been limited for the past few years by a 
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techical challenge relevant to a possible particle agglomeration while they are introducing 
into the microchannel. Fortunetely, as a new functional microfluidic channel with 
micromagnet, which can allow for effectively manipulating the FNs to flow into the channel 
one by one, has been recently developed (Lagae et al., 2002; Ramaden et al., 2006; Latham et 
al., 2007), the interests to apply a single FN sensor agent to an in-vitro GMR biosensor for 
SMD are dramtically increased in a molecular diagnostic biosensor system.  
In this chapter, the physical characteristics of an in-vitro GMR biosensor with an 
immoblized single FNSA is mainly discussed to provide crucial information how to 
optimize its strucure for SMD. In chapter 2, the sensing performance of an in-vitro GMR 
biosensor with an immobilized FNSA or SPNSA is numerically analyzed based on the 
“Stoner-Wolfarth model” to evaluate which GMR biosensor system is more suitable for 
SMD. In chapter 3, the optimization of sensor geometry considering the spatial magentic 
field interaction between the FNSA and the FL as well as the physical correlation between 
the “effective sesning area” and SNR is introduced to successfully design an in-vitro GMR 
biosensor enabling to show maximized SNR for SMD. Finally, chapter 4 discusses the newly 
desgined sensoror structure of an in-vitro GMR biosensor with a specially designed 
magnetic shield layer (MSL) to explore its technical effectiveness for the diagnostic 
biosensor applications based on SMD.  
2. An in-vitro GMR biosensor with an immobilized single FNSA or SPNSA for 
SMD 
To confirm which sensor system is more promising for SMD, the sensing performance of an 
in-vitro GMR biosensor with an immobilized FNSA or SPNSA should be first clarified. Four 
physical sensing parameters: (1) the relative MR change (δR) relevant to the magnetization 
angle difference between the free layer (FL) (sensing layer) and the pinned layer in GMR 
spin-valves, (2) the interaction factor (IF) describing the magnetic spatial interaction 
between the FL and the nanoparticle sensor agent, (3) the distance between the single 
immobilized FNSA or SPNSA and the FL, and (4) the practically allowable sensor size 
considering the physical limit of current sensor fabrication technology, are mainly 
considered for the comparison of sensing performance. The numerical analysis is based on 
the “Stoner-Wolfarth model” describing that the magentizations of the FL in the GMR 
biosensors are coherently rotated under a globally applied magentic field with two-
dimensional field components, which are homogeneous across the entire FL.  
2.1 Physical model of spatial field distribution on an in-vitro GMR biosensor 
The sensing mechanism of a GMR biosensor with an immobilized single FNSA or SPNA is 
illustrated in Fig. 1-(a). The sensor agents are captured on the FL surface of GMR biosensor 
through a bio-recognition process and the resistance of the GMR sensor is accordingly 
changed by the stray field produced from the magnetic nanoparticles. As shown in Fig. 1, the 
critical geometry parameters considered for the numerical calculation include the spacing 
between the SA and the sensor surface (h), and the geometry of FL, e.g. length (L), width (W), 
and thickness (t). Figure 1-(b) describes the magnetization configuration of FL in the GMR 
biosensor and the magnetic spatial interaction between the SA and the FL. The magnetization 
of pinned layer (PL) is exchange biased to the negative transverse direction (-y) and the easy 
axis (EA) of the FL is along the longitudinal direction (+x) due to shape anisotropy and 
crystalline anisotropy. To minimize the geometrically-induced magnetostatic coupling 
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between the FL and the orthogonally coupled PL, the PL is considered as the “synthetic anti-
ferromagnetic (AFM) layer”, e.g. FM/non-magnetic/FM structure. The magnetization of 
FNSA is aligned in the positive transverse direction (+y) and the SPNSA is magnetized toward 
the positive transverse direction (+y) by the excitation field (+y) for comparison with the 
FNSA. In order to establish a physical model for the stray field induced by the magnetic 
nanoparticles, the single magnetic nanoparticle with spherical shape is assumed to be 
uniformly magnetized and has an effective dipole magnetic moment (m). The field intensity, 
H(H ≅ B in cgs unit) at a distance r can be expressed by equation (1) (Besse et al., 2002).  
 
r
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The spatial distributions of the stray field induced by the magnetic nanoparticle on the FL of 
GMR biosensor are numerically calculated by considering the both longitudinal and 
transverse magnetic field components of an ideal dipole, as illustrated in Fig. 1-(b).  
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Fig. 1. A schematic diagram of an in-vitro GMR biosensor with a single nanoparticle sensor 
agent for SMD (a) the molecular recognition process on the GMR biosensor surface, (b) the 
magnetic spatial interaction between the magnetic nanoparticle agents and the FL of GMR 
biosensor. All the field components generated from the bias field, Hb, the excitation field, Ht 
and the magnetic nanoparticles are illustrated on the FL sensor surface, and (c) a schematic 
diagram of magnetization configuration of a single magnetic nanoparticle and its variation 
due to the magnetic dipole interaction caused by the x-component of FL magnetization to 
the FNSA or the  SPNSA. 
www.intechopen.com
 Intelligent and Biosensors 
 
166 
The total free energy in the FL is described by equation (3) based on the “Stoner- Wolfarth 
model” (Stoner & Wolfarth, 1948). 
 θθθψθθ cossin)cos(sin)(
2
1
sin 22 sbstssxzu MHMHHMMNNKE −−−−−+=  (3) 
Where H is the stray field generated by the magnetic nanoparticles, which can be divided 
into xH  and yH , respectively. The demagnetizing factors can be determined by equation 
(4) (William, 2001). 
 22/8 wlltwN z += , 22/8 wlwtwN z +=  (4) 
According to the “Stoner- Wolfarth model”, the magnetization direction of the FL (FL is in a 
single domain state as the sensor size is in submicron range in this model) is determined by 
the minimization of the total free energy as shown in equation (3). Hence, the total free 
energy with respect to θ (Fig. 1-(c)) is minimized. Our method is to set up a discrete array of 
θ. The range of this array is from 0 to 2π and the step size is 0.00001. With such small step 
size, the range of θ can be considered as a continuous range. By substituting the array into 
equation (3), the minimized energy and the corresponding θ can be obtained using a simple 
algorithm. The next step is to use the following equation (5) to calculate the 
magnetoresistance (MR) ratio based on the magnetization (spin) configuration of GMR 
biosensor where the magnetization direction of PL is exchange biased to a fixed direction (-y). 
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Where fθ and pθ  are the angles of the FL, and the PL with respect to EA, respectively; 
0)/( RRΔ is the MR ratio of the GMR biosensor when the FL and PL is antiparallel with each 
other, which is also the maximum MR ratio for a GMR biosensor. To evaluate the sensing 
performance, the relative MR change, δR, is needed to be defined by equation (6). 
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Where withRR )/(Δ  indicates the MR ratio of GMR biosensors due to the nanoparticle sensor 
agents immobilized on the surface of FL, withoutRR )/(Δ  indicates the MR ratio without 
nanoparticle, especially SPNSA, on the surface of FL. Moreover, in equation (6), the θf,without 
is the angle between FL magnetization and EA when no sensor agent is on the sensor 
surface and the θf,with is the angle between FL magnetization and EA when the sensor agent 
is on the sensor surface. For FNSA, the θf,without is zero, thus δR can be written by 
withfR ,sin5.0 θδ = . For SPNSA, the θf,without is not zero due to the excitation field (see Fig. 1-
(b)) and thus the δR can be rewritten by θθ df ⋅cos5.0  , where, θd  is the angle difference 
before and after the SPNSA captured on the sensor surface (dθ = θf,without - θf,with ). The fringe 
field from the FL of GMR biosensors is also considered to affect the magnetic properties of 
nanoparticle sensor agent in both magnetization direction and magnetic moment due to the 
magnetic dipole interaction between the FL and the nanoparticles (see Fig. 1-(b)). 
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Accordingly, the effect of fringe field from the FL on the δR is included in this model to 
precisely interpret the sensing performance. To find out how many percentages the FL 
fringe field would influence on the magnetic moment of the magnetic nanoparticles, the 
interaction factor (IF) defined as (%)100)/cos1( ' ⋅−= mm βα  is employed, where 'm  is the 
magnetic moment considering the effect of the FL fringe field, m  is the original magnetic 
moment and β is the angle difference between the original magnetization of sensor agent 
and the rotated magnetization due to the fringe field from FL as shown in Fig. 1-(c). In this 
model, the FNSA is considered as a CoFe2O4 nanoparticle. It has a remnant magnetization of 
22 emu/g and a diameter of 26 nm (see Fig. 2-(a) and (b)). The magnetic moment of the 
CoFe2O4 nanoparticle is calculated using VMm rπ4ˆ = , where rM  is the remnant 
magnetization and V is the volume of the CoFe2O4 nanoparticle. Since the CoFe2O4 
nanoparticle has a large remnant magnetization, the excitation field ( tH ) is not required, 
thus the equation (3) can be simplified by equation (7), 
 ffbffyffxffxzfu MHMHMHMNNKE θθθθθ cossincossin)(
2
1
sin 22 −−−−+=  (7)  
Due to the fringe field from the FL of GMR biosensor ( HΔ ), the induced magnetic moment 
of the CoFe2O4 nanoparticle becomes Hm f Δ⋅=Δ χ , where fχ is considered as constant 
because the fringe field is relatively small. In addition, by considering the single domain 
state of CoFe2O4 nanoparticle agent, the magnetization direction of the CoFe2O4 nanoparticle 
can be calculated using the “Stoner- Wolfarth model” as below: 
 
33
'''2'
)2/2/(
sin
,
)2/2/(
cos
cossincossin)(
2
1
Dth
lwtM
H
Dth
lwtM
H
mHmHmHmHHE
ff
y
ff
x
byxdu
++=Δ++=Δ
−Δ−Δ−+=
θθ
ββββ
 (8) 
where mmm Δ+=' , and xHΔ , and  yHΔ are the longitudinal, and transverse component of 
the FL fringe field, respectively. As the saturation magnetization of the CoFe2O4 
nanoparticle sensor agent is almost the same as the bulk CoFe2O4 ferrite, the anisotropy 
constant, K1,  of the sensor agent is assumed as bulk value of CoFe2O4 ferrite, which is a 
2×106 erg/cm3 and thus '1 /2 mKHu = . The demagnetizing factor is considered as 3/4π   
thus, 3/4' π⋅= mHd . 
The SPN used in this model is also a single CoFe2O4 nanoparticle but the diameter is a 7 nm 
as shown in Fig. 2-(c) and (d). As can be seen in the inset of Fig. 2-(c), the magnetic 
susceptibility, χ, of the superparamagnetic CoFe2O4 nanoparticle is almost constant at a 
0.041 independent of applied magnetic field. Using the experimentally obtained χ value, the 
magnetic moment of the superparamagnetic CoFe2O4 nanoparticle under the bH  and the 
tH  is determined at 3/43/4ˆ
33 zHrxHrm tb χπχπ +=  and the total free energy can be 
correspondingly re-written by equation (9). 
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As the χ value is constant and there is no magnetic anisotropy energy under no excitation 
field, the IF for the superparamagnetic CoFe2O4 nanoparticle sensor agent can be simplified 
as tyy HH /Δ=α , where  yHΔ  is the y component of the FL fringe field from GMR biosensor. 
 (%)100
)2/2/(
sin
3
×++= t
fs
HDth
lwtM θα  (10) 
 
 
Fig. 2. (a) The hysteresis loop of CoFe2O4 FNSA with a 26 nm particle size, and (b) the SEM 
(Scanning Electron Microscopy) image of the CoFe2O4 FNSA, (c) the hysteresis loop of 
CoFe2O4 SPNSA with a 7 nm particle size. The inset shows the minor hysteresis loop 
measured at a ± 300 Oe, and (d) the TEM (Transmission Electron Microscopy) image of the 
CoFe2O4 SPNSA.  
2.2 Comparison of sensing output performance 
Based on the physical model developed in section 2.1, the sensing output performance of an 
in-vitro GMR biosensor with a single immobilized FNSA or SPNSA is calculated and 
compared. Figure 3 shows the dependence of sensor width at the fixed sensor geometry 
(sensor aspect ratio) on the δR and the IF of the in-vitro GMR biosensors. The sensor width, 
W, of the GMR biosensor is changed from 10 to 80 nm at the different aspect ratio (L : W) 
changed from 3 : 1 to 10 : 1. The purpose of changing the sensor aspect ratio is to explore the 
effects of vortex magnetization on the surface of FL due to the geometrically-induced 
demagnetizing factor (Girgis et al., 2000). The Hb, and the h are fixed at a 50 Oe, and a 30 
nm, resepctively for precise comparison. The CoFe2O4 FNSA, and SPNSA has a mean 
particle size of 26 nm and 7 nm, resepctively. The δR and its variation due to the change of 
W is numerically analyzed by considering both the “effective sensing area”, which is 
defined as the area formed on the FL surface whose magnetic spins can be coherently 
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rotated by the stray magnetic field induced by the sensor agent, and the development of 
“inactive sensing area”, which is not responded by the stray field, due to the increase of IF 
induced by the geometrically-increased magnetic anisotropy of FL.  
 
 
Fig. 3. The physical dependence of sensor width, W, on the relative MR, δR, and the 
interaction factor, IF, (a) δR, GMR biosensor with a FNSA, (b) IF, GMR biosensor with a 
FNSA, (c) δR, GMR biosensor with a SPNSA, and (d) IF, GMR biosensor with a SPNSA. 
As shown in Fig. 3, the in-vitro GMR biosensors with an immobilized single FNSA or 
SPNSA exhibit the same physical characteristics that the δR is abruptly decreased above the 
maximized value obtained at the optimized sensor width, Wop, and that the IF is almost 
squarely increased, by increasing the W as well as the aspect ratio. This is supposed to be 
due to the increase of “inactive sensing area” and the magnetic anisotropy of FL induced by 
the increased sensor size proportional to the W. However, it is clearly noted that the 
absolute δR and IF values of the in-vitro GMR biosensor with a FNSA are much larger than 
those with a SPNSA. As can be clearly seen in Fig. 3-(a) and (c), the δR obtained from the in-
vitro GMR biosensor with an aspect ratio of 3: 1 (75 nm (L) × 25 nm (Wop)) and an 
immobilized FNSA is a 2.72 %, while the δR for the in-vitro GMR biosensor with a  SPNSA, 
which has the same aspect ratio (45 nm (L) × 15 nm (Wop)), is a 0.013 %. In addition, the 
variation of IF values depending on the W of the in-vitro GMR biosensor with a FNSA is 
negligibly small compared to those with a SPNSA as shown in Fig. 3-(b) and (d). The 
practically allowable sensor size based on the physical limit of current sensor fabrication 
technology, especially nanoelectronics technology, is another physical parameter to be 
considered in evaluating the sensing performance. Considering the patterning limit of EBL 
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(Electron Beam Lithography) technique (> 50 nm) and the geometrically-induced 
demagnetizing factor of FL directly relevant to the sensor aspect ratio and the IF, the 
minimum sensor size can be determined in the range between 150 nm (L) × 50 nm (W) and 
250 (nm) × 50  nm (W). However, as verified in Fig. 3-(a) and (c), the δR values obtained 
from these sizes of in-vitro GMR biosensor with a SPNSA are too small to be considered for 
a real biosensor application.  
According to the numerically analyzed sensing performance summarized in Fig. 3, it is 
clearly demonstrated that an in-vitro GMR biosensor with an immobilized single CoFe2O4 
FNSA is more suitable for SMD due to its higher δR, less IF dependence, and practically 
allowable sensor size. The large remnant magnetization of single CoFe2O4 FNSA allowing to 
produce a sufficiently large stray field and to maintain extremly small variation of IF is the 
main physical reason for the technical promise of GMR biosensor with an immobilized 
single FNSA for SMD.  
3. Optimizing the sensor geometry of an in-vitro GMR biosensor with an 
immobilized FNSA for SMD 
In this chapter, the detailed spatial magnetic field interactions between the single CoFe2O4 
FNSA and the FL of an in-vitro GMR biosensor is numerically analyzed to predict the 
optimized sensor geometry that maximizes the sensng perfromance for SMD prior to 
fabrication. In order to more accurately analyze the spatial magentic field interactions on the 
FL surface, the longitudinal and the transverse components of the stray field produced by 
the FNSA are considered. The optimized sensor geometry at a given remnant magentic 
moment of the FNSA is predicted by evaluating the “effective sensing area”. The optimized 
sensor geometry is expressed in terms of the effective distance (δ), which includes the 
radius, a, of FNSA, the length of biological entities (especially, DNA including probe), 
membrane thickness, and the passivation layer, as well as the critical sensor length (lc), and 
the critical sensor width (wc). The experimentally demonstrated sensing performance of an 
in-vitro GMR biosensor with an immobilized CoFe2O4 FNSA is also compared to the 
numerically calculated sensing performance to confirm the effectiveness of the physical 
model introduced in this chapter.  
3.1 Analytical model for optimizing sensor geometry and geometrical parameters 
Figure 4 shows the schematic diagram of an in-vitro GMR biosensor with an immobilized 
single FNSA (a) and the typical MR curve (b) obtained from the Si/Ta/Ni80Fe20/Ir22Mn78/ 
Co84Fe16/Ru/Co84Fe16/Cu/Co84Fe16/Ni80Fe20/Ta exchange biased synthetic GMR spin-
valve biosensor. For the numerical calculation, it is assumed that the CoFe2O4 FNSA has an a 
= 250 nm, and a mass density of 5.29 g/cm3 (Lee et al., 2007). By considering only the 
logitudinal field compoent of the stray field produced by the immobilized single CoFe2O4 
FNSA, Bx on the surface of FL along the x and y axis from equation (2) is simplified by 
equation (11) (Schepper et al., 2006). 
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The calculated magnetic field distribution and the two geometrically critical parameters, 
which are essential to determine the optimized sensor geometry, are also denoted in Fig. 4-
(a). The geometrical parameters of the in-vitro GMR biosensor with an immobilized single 
FNSA are first determined by considering the longitudinal component of the stray field. The 
effective magnetization, β, is defined as the ratio of the total magnetization of the CoFe2O4 
FNSA to the longitudinal field component of the stray field, xBm /=β . The δ is defined as 
ah +=δ . The geomtrical parameters, the lc, and the wc for achieving the optimized sensor 
geometry, which maximize the sensor output performance, are dependent on β and δ. These 
geometrical parameters, which determine the “effective sensing area”, cc wl × , are derived 
from equation (11) by considering x and y at the points where Bx is equal to the sensor 
switching field, Bsw (with xsw Bm /≡β ). The finally determined lc, and wc are given by, 
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The insert in Fig. 4-(b) highlights the two characteristic parameters relevant to the operation 
of the in-vitro GMR biosensor; the Bsw  and the detectable field limit (BDL) directly associated 
with the exchange bias field of the in-vitro GMR biosensor, are defined in terms of the 
intensity of stray field produced by the single CoFe2O4 FNSA. The critical effective distance, 
δc, can be obtained by considering the operating conditions of the GMR biosensor including 
Bsw, BDL, and the Mr of the single CoFe2O4 FNSA. If Bx is in the sensor operating range, 
Bsw<Bx<BDL, δ can be expressed as a function of β. On the other hand, if Bx is smaller than 
Bsw (Bsw>Bx), then  0== cc wl . Thus, the critical effective distance, δc, for the sensor 
  
 
Fig. 4. (a) A schematic diagram of in-vitro GMR biosensor with an immobilized single 
FNSA, the field distribution , and the definition of geometrical parameters considering for 
optimizing sensor geometry, and (b) a typical MR curve of GMR biosensor and the 
definition of two sensing characteristics parameters. 
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operation based on the non-switching conditions: Bsw>Bx, and equation (12) can be 
determined at 3 βδ =c . In addition, from equation (12), the aspect ratio, cc lw /  for the 
optimized sensor geometry can be expressed by equation (13). 
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The numerically analyzed magnetic field distribution on the surface of the FL finally 
obtained by equation (13) clearly demonstrates that the optimized geometrical parameters, 
lc, and wc are directly relevant to δ and swβ . In order to more accurately predict the 
optimized sensor geometry based on the “effective sensing area, cc wl × ”, the numerical 
calculation is extended to two dimensional field component, both longitudinal and 
transverse field components, on the FL surface. The “Stoner- Wolfarth model” (or the 
“asteroid curve model”) is employed for the detailed calculation (Hirota et al., 2002).  
3.2 Optimizing the sensor geometry considering the one dimensional (longitudinal) 
field component 
As described in the analytical model developed in section 3.1, the optimization of sensor 
geometry with an immobilized CoFe2O4 FNSA is based on the determination of lc, and wc by 
considering the longitudinal field component of Bx, and By, on the FL surface. Figure 5 shows 
the contour diagrams of the magnetic field intensity and its distributions, Bx, and By on the FL 
surface as a function of δ (for  δ = 0.5, 1.0, and 2.0 μm). As can be seen in Figs. 5-(a), 5-(c), and 5-
(e), the maximum Bx is rapidly decreased from 691.2 to 10.8 G by increasing δ from 0.5 to 2.0 
μm. As shown in Fig. 4-(b), the in-vitro GMR biosensor considered in this model is operated at 
magnetic field intensity in the range from 12 G (Bsw) to 176 G (BDL). Considering these the 
magnetic characteristics of GMR biosensor, the shaded region observed at δ = 0.5 μm due to 
the large field intensity (Fig. 5-(a)) and all the regions shown in Fig. 5-(e) do not contribute to 
the sensor operation. This indicates that the lc and the wc for the optimized sensor geometry 
based on equation (12) should be determined at δc < 0.79 μm, which corresponds to the sensor 
operating condition of DLx BB ≤ . Furthermore, by combining the calculated value of δc with 
the physical parameters of single CoFe2O4 FNSA and equation (12), the lc, and the wc are 
determined to be ~ 1.12 μm, and ~ 3.52 μm. Based on the numerical calculation, the aspect 
ratio ( cc lw / ) for the optimized sensor geometry of in-vitro GMR biosensor with an 
immobilized single CoFe2O4 FNSA (a = 250 nm) is determied at 14.3/ =cc lw .  
The calculation results shown in Fig. 5 clearly demonstrates that the geometrical and 
systematic design parameters (δ, lc, and wc) of the in-vitro GMR biosensor for producing a 
highly stable sensing performance can be precisely predicted prior to fabrication if the 
remnant magnetization of the single CoFe2O4 FNSA and the GMR characteristics of the 
sensor are known. 
3.3 Optimizing the sensor geometry considering the longitudinal and transverse field 
components  
Dependence of δ on the transverse component, By, is also estimated to confirm its physical 
contribution to the optimization of in-vitro GMR biosensor geometry. Figure 5-(b), 5-(d), 
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Fig. 5. Calculated contour diagrams of the longitudinal (left column) and transverse (right 
column) components of the magnetic field produced by an immobilized CoFe2O4 FNSA on 
the FL surface where δ is varied from 0.5 to 2.0 μm. The area defined by the dashed-dotted 
line and the shaded region show the optimized sensor geometry, and the undetectable 
region, respectively. 
and 5-(f) show the contour diagrams of By as a function of δ changed from 0.5 to 2.0 μm. 
Similar to the calculation results shown in Figs. 5-(a), 5-(c), and 5-(e), the By has a strong 
dependence on δ. However, the distribution of By is completely different from Bx. The 
distribution of Bx on the FL surface shows an ellipsoidal shape with the major axis along the 
y-axis, while By exhibits a distribution that has a maximum and minimum field intensity of 
max,max, 3/1 xy BB ≈  at the position of (±δ, ∓ δ). The numerical comparison between Bx and By 
depending on δ suggests that both components of the stray field should be simultaneously 
www.intechopen.com
 Intelligent and Biosensors 
 
174 
considered for a more accurate prediction of the sensor geometry. Accordingly, the “Stoner- 
Wolfarth model”: 3/23/23/2 yxk HHH += , is employed to accurately analyze the spatial 
magnetic field distribution and intensity on the FL surface. Even though the “Stoner- 
Wolfarth model” assumes that the FL magnetizations are coherently rotated by the stray 
field and are homogneous across the entire FL surface, this model is considerably useful in 
interpreting the physical behavior of the in-vitro GMR biosensor under a highly localized 
magnetic dipole field from the immobilized single CoFe2O4 FNSA. Figure 6 shows the 
magentic field distribution and intesity considering both the logitudinal and transverse field 
components with different effective distances: δ = 0.5, 1.0, and 2.0 μm. Unlike the ellipsoidal 
shape of the “effective sensing area” shown in Fig. 5, the coherently rotated magnetization 
of the FL induced by two-dimensional magnetic field components shows a more 
complicated and extended “effective sensing area” due to the contribution of the transverse 
field component. Figure 7 shows the optimized sensor geometry (white line) and the 
“effective sensing area” (bright gray region) calculated by considering the one-dimensional 
 
 
Fig. 6. The magnetic field distribution and intensity on the FL surface calculated by 
considering the longitudinal and transverse field components at the different effective 
distance of δ. (a) 0.5, (b) 1.0, and (c) 2.0 μm 
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(Fig. 7-(a)) and the two-dimensional components (Fig. 7-(b)) based on the “Stoner- Wolfarth 
model”. Although the numerical values of optimized geometrical parameters determined at 
the effective distance of δ = 0.79 μm are the same as lc = 1.12 μm, and wc = 3.52 μm, the 
“effective sensing area” directly relevant to the sensing output performance is completely 
different. As can be seen in Fig. 7-(b), the “effective sensing area” is extended due to the 
transverse field component. This correspondingly results in enhancing the output signal of 
the in-vitro GMR biosensor. However, as can be also seen in Fig. 7-(b), an undetectable area 
in the vicinity of center of the optimized sensing area is developed due to the spatial 
magnetic field interaction. Making a GMR biosensor with a larger exchange bias field and 
introducing a specially designed sensor structure with a high permeability magnetic shield 
layer are suggested as an effective solution for the undesirable technical problem. 
 
 
Fig. 7. Comparison of the optimized sensor geometry (square region) and the “effective 
sensing area” calculated by considering the (a) one-dimensional filed component, and (b) 
two-dimensional field component on the FL surface.  
3.4 Demonstration of sensing performance of the in-vitro GMR biosensors with 
optimized sensor geometry  
The sensing performance of an in-vitro GMR biosensor with an immobilized CoFe2O4 
ferrimagentic nanobead SA geomtrically optimized by the analytical model developed in 
chapter 3.1 is demontrated to confirm its practical effectiveness. The CoFe2O4 nanobead with 
a mean raius, a, of 925 nm synthesized by using a modified sol-gel mehtod is considered as a 
ferrimagentic nanobead SA. The optimized sensor geomtry of the in-vitro GMR biosesnor 
based on the equations (11) ~ (13) as well as considering a 925 nm of mean nanobead size is 
calcuated to determine the “effective sensing area, cc wl × ”. The sensing output performance 
of the optimized GMR biosensors is evaluated as a function of sensor length, l, at the fixed 
wc by controlling the size of CoFe2O4 nanobead SA, which is systematically varied in the 
range of a = 925 nm ± 20.5 % as shown in Fig. 8-(a).  
The controlled nanobead size leads to changing the l at the fixed wc due to the variation of 
stray field intensity caused by the change of effective distance. The GMR biosensor used for 
this demosntration has a strucutre of Si/Ta(5)/Ni80Fe20(2)/Ir22Mn78(20)/Co84Fe16(2)/ 
Ru(0.75)/Co84Fe16(2)/Cu(2.3)/Co84Fe16(0.5)/Ni80 Fe20(2.5)/Ta(3 nm) and is patterned by 
using an electron beam lithography (EBL) and a typical photolithography. The patterned 
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Fig. 8. (a) Schematic diagram of in-vitro GMR biosensors with an immobilized CoFe2O4 
ferrimagentic nanobead SA with different bead sizes controlled in the range of a = 925 nm ± 
20.5 %, (2) the patterned GMR biosensor with the geomtry of l = 1 μm, and wc = 5 μm, and 
(c) GMR behaviour. 
GMR biosensor structure and its GMR behaviour for the before and after patterning, and for 
the hard axis response are shown in Figs. 8(b), and (c), respectively. As can be seen in Fig. 8-
(a), the magnetization of FL is orthogonally coupled to the pinned layer, and the stray field 
produced by the single CoFe2O4 nanobead SA is applied to the hard axis of FL 
magnetization for the detection of output sensing signal. 
On the basis of the numerical analysis, the intensity of stray field produced by the CoFe2O4 
nanobead SA with a radius of 750 (-20.5 %, negative standard deviation), 925 (mean nano 
bead size), and 1150 nm (+20.5 %, positive standard deviation) is calculated by considering 
the experimentally obtained Mr values to determine the lc. The calculated maximum field 
intensity is a 67.8, 116.5, and 177.1 Oe (G), respectively and the lc is revealed to be a 0.85, 
1.08, and 1.31 μm, respectively at the fixed wc = 5 μm. Figure 9 shows the detected output 
signal obtained from the in-vitro GMR biosensor shown in Fig. 8-(b). The detected signal is 
captured by using an oscilloscope. As can be clearly seen in Fig. 9-(a), when a DC magnet 
with a constant field of 103 Oe (G) is brought proximity to the GMR biosensor, an output 
signal of Vout = 6.13 mV (Voutput = 613 mV after 100 times amplication using a 741 OP-AMP) 
is successfully achieved. This is attributed to the MR change of the GMR biosensor, ΔR/R0 = 
2.2 %, which is exactly equal to the maximum MR ratio obtained along the hard-axis of the 
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patternd GMR biosensor shown in Fig. 8-(c). At a 103 Oe (G) of field intensity, the “effective 
sensing area”, cc wl ×  induced by the DC magnetic field intensity is larger than the 
patterned sensor geomtry of l = 1 μm, and w = 5 μm. This indicates that all the FL 
magnetizations are fully rotated by the applied DC magnetic field resulting in exhibiting the 
maximum MR ratio of 2.2 %. In contrast, the output signals obtained from the in-vitro GMR 
biosensors activated by the CoFe2O4 nanobead SAs show a strong dependence on the size of 
nanobead SA. As can be seen in Figs. 9-(b), (c), and (d), the output voltage and the ΔVout/V 
of the GMR biosensor activated by the CoFe2O4 nanobead SA with a size of 750, 925, and 
1150 nm are Vout = 6.07 mV (ΔVout/V = 1.2 %), Vout = 6.12 mV (ΔVout/V = 2.0 %), and Vout = 
6.10 mV (ΔVout/V = 1.7 %), respectively. Even though the non-uniformity and the position 
dependent stray field intensity produced by the nanobead SA can be considered to be 
partially influenced on the variation of output sensing signal, the observed sensing signal 
depending on the size of nanobead SA is primarily interpreted in terms of two physical 
parameters: (a) the change of stray field intensity relevant to the switching field, and (b) the 
“inactive sensing area” as well as the development of “undetectable sensing area”. As can be  
 
 
Fig. 9. Output sensing signal captured from the in-vitro GMR biosensor with geometry of l = 
1 μm and w = 5 μm. (a) activated by DC magnet, (b) activated by 750 nm size CoFe2O4 
nanobead SA, (c) activated by 925 nm size CoFe2O4 nanobead SA, and (d) activated by 1150 
nm size CoFe2O4 nanobead SA. 
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confirmed from the calcualtion results, the 0.85 μm of lc determined by the 750 nm size of 
nanobead SA at the fixed wc = 5 μm is smaller than the geometry of patterned GMR 
biosensor, l = 1 μm and w = 5 μm, that results in the reduction of MR ratio due to the 
“inactive sensing area”. In addition, the reduced stray field intensity due to the decrease of 
nanobead size leads to the reduction of switching field that results in a lower output sensing 
signal as shown in Fig. 8-(c). The slight decrease of output sensing signal obtained from the 
GMR biosensor with an 1150 nm size nanobead SA is thought to be due to the development 
of “undetectable sensing area” as shown in Fig. 7-(b). The large stray field intensity, around 
177.1 Oe (G), obtained from the large size of nanobead SA is comparable to the exchange 
bias field of the patterned GMR biosensor. This induces the partial magnetic reversal of 
pinned layer resulting in a slight MR degradation. Furthermore, the spatial magnetic field 
interaction due to the large stray field intensity causes to form an undesirable “undetectable 
sensing area” at the central region of FL surface of the patterned GMR biosensor that leads 
to the reduction of MR ratio as well as the output sensing signal.  
4. Effects of a specially designed magnetic shield layer (MSL) on the sensing 
performance of an in-vitro GMR biosensor with an immobilized single FNSA 
for SMD 
As previously discussed, the in-vitro GMR biosensor with an immobilized single CoFe2O4 
FNSA is suitable for SMD. However, accoridng to the numerical analysis on the spatial field 
interaction of the stray field, which is produced by a single FNSA, on the FL surface, the 
field distribution is found to be so complicated and non-uniform that it can not be easily 
interpreted. In particular, the creation of “undershoot field regions”, which are formed at 
both edges of the maximum field intensity regions as well as the central regions of FL 
surface resulted from the spatial magnetic field interaction, is revealed as the most severe 
problem to induce the reduction of output sensing signal and the sensing stability of the in-
vitro GMR biosensor. Thus, a new sensor structure, which can solve this technical challenge, 
is urgently required in a molecular based diagnostic GMR biosensor system for achieving 
more stable SMD.  
In this chapter, a new structure of in-vitro GMR biosensor with a specially designed 
magnetic shield layer (MSL) is introduced and discussed based on the numerically analyzed 
calculation results to explore its effectiveness for the improvement of sensing performance 
as well as the sensing stability. The effects of MSL thickness including magnetic 
permeability of MSL, and gap width of MSL on the change of “undershoot field” as well as 
the “stray field intensity” are primarily discussed to demonstrate the physical contribution 
of MSL to the sensing performance of the in-vitro GMR biosensor considering for SMD. 
4.1 Designing of in-vitro GMR biosensor with magnetic shield layer (MSL) 
Figure 10-(a) shows a schematic diagram of an in-vitro GMR biosensor with a specially 
designed MSL. As shown in Fig. 10-(a), the in-vitro GMR biosensor has a single CoFe2O4 
FNSA immobilized on the FL surface with a distanace of h μm, which is defined as the 
distacne between the FNSA and the FL surface of the GMR bionsensor. Accoridng to the 
physical model nuemrically developed in chapter 3.1 (Schepper et al., 2006), the h can be 
expressed as equation (14), 
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In this numerical calculation, an IrMn based exchange biased GMR spin-valve device is 
considered as a sensing element. Thus, to achieve a stable sensing performance, the 
maximum field intensity produced by the single FNSA should be adjusted to be lower than 
the exchange bias field of the GMR biosensor. Considering this sensor operating condition, 
BDL is determined based on the experimentally obtained exchange bias field from the 
patterned GMR biosensor.  
 
 
Fig. 10. (a) A schematic diagram of an in-vitro GMR biosensor with a specially designed 
MSL, and (b) the distribution of x-component of stray field produced by an immobilized 
single CoFe2O4 FNSA, with (solid line) and without (dashed line) MSL 
For the numerical calculation based on equation (14), a radius of 250 nm size CoFe2O4 
FNSA, an 176 G of exchange bias field, and a 0.48 μm of h are considered. As can be seen in 
Fig. 10-(a), the calcualted h value includes FL/passivation layer (40 nm)/MSL (0 ~ 300 
nm)/Al2O3 functional membrane (140 nm; including a length of biological entities such as 
ten sequence of DNA: 34 nm). The Al2O3 functional membrane layer in this sensor structure 
is used for both maintaing the h depending on the variation of MSL thickness and 
immobilizing the FNSA using a membrane probe. The high magnetic permeability of 
materials such as supermalloy and permally are considered as a MSL in this structure. 
Figure 10-(b) shows a longitudinal field component (x direction) of stray field intesity on the 
FL surface without (solid line) and with (dashed line) MSL. The distribution of magentic 
field intensity shown in Fig. 10-(b) is calcualted as a function of distance from the center 
point of FNSA to the edge of GMR biosensor along the x direction. In addition, Bmax, BU1, 
BU2, and leff are denoted as a maximum magentic field intensity, an undershoot field, an 
outer undershoot field, and an effective detectable length, which is the region enabled to be 
reversed by the stray field, respectively. 
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(a) (b) 
(c) (d) 
4.2 Effects of magnetic shield layer (MSL) on the sensing performance of in-vitro GMR 
biosensor for SMD 
The MSL has a basic geometry of 300 nm thickness, a permeability of supermalloy (5.2 × 
105), 1.2 μm gap width, and 8 μm length. To explore the effects of MSL on the sensing 
performance, the physical parameters of the MSL including its thickness, its gap width, and 
its permeability are changed from the basic structure. Figure 11 shows the dependence of 
MSL thickness on the sensing performance compared in terms of the physical sensing 
parameters such as BU1, Bmax, leff, and BU2. As can be seen in Fig. 11-(a), the undesirable 
“undershoot field region”, BU1, is dramatically reduced when the MSL has a 1 nm of 
thickness. By further increasing its thickness, BU1 is sharply decreased and then it is 
completely removed above tMSL = 100 nm. This indicates that the MSL needs to have a 
critical thickness to build up a close magnetic flux between the FNSA and the MSLs 
allowing for a distinct magnetic shielding effect. Figure 11-(b) shows the dependence of 
MSL thickness on the change of Bmax. When the MSL has a 10 nm of thickness and above, the 
Bmax is decreased down to 158 G and then it saturates at 153 G by further increasing the MSL 
thickness above 100 nm. This numerical result along with the increase of leff shown in Fig. 
11-(c) indicates that the effects of MSL on the improvement of sensing performance of the in-
vitro GMR biosensor are quite prominent. The reduction of Bmax from 188 G (above BDL) to 
155 G  (below the exchange bias field degradation point) and the increase of lc of the sensing 
area due to the MSL shielding effects allow the dramatic increase of “effective sensing area” 
on the FL surface that leads to the increase of sensing output signal of the patterned GMR 
biosensor. However, as can be seen in Fig. 11-(d), the magnetic dipole field induced in the 
MSL due to its high magnetic moment generates another undesirable small “undershoot 
field”, BU2 at the vicinity of the MSL edges. Even though its numerical value is small below 
 
 
Fig. 11. Effects of MSL thickness on the sensing performance of an in-vitro GMR biosensor 
with an immobilized 250 nm size CoFe2O4 FNSA. (a) BU1, (b) Bmax, (c) leff, and (d) BU2 
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(a) (b) 
(c) 
(d) 
12 G, it should be carefully controlled when the MSL is used for especially multi-array 
sensor architecture. The effects of MSL permeability on the sensing performance is not 
discussed in details in this chapter as all the physical sensing parameters have the same 
dependence on the permeability of MSL. However, the numerical calculation results 
obtained from the GMR biosensor with geometry of a 300 nm MSL thickness, a 1.2 μm of 
gap width, and a 8 μm of MSL length demonstrates that the MSL with magnetic 
permeability of at least 100 shows obvious shielding effects. Figure 12 shows the 
dependence of MSL gap width, which is changed from 0.2 to 2.0 μm, on the sensing 
performance of an in-vitro GMR biosensor with an immobilized CoFe2O4 FNSA. As shown 
in Fig. 12-(a), the Bmax is dramatically increased from 150 G to 260 G, which is beyond the 
sensing limit, BDL, by decreasing the gap width from 0.8 to 0.2 μm. The dramatic increase of 
magnetic field intensity at the gap width below 0.8 μm is mainly thought to be attributed to 
the increase of fringe field produced from the gap between two MSLs (This is quite similar 
to the “fringe field” produced by the head gap from the writer in magnetic recording 
technology) (Bertram, 1994). The high permeability of two MSLs, which are closely faced 
each others with small gap, can produce a strong “deep gap bubble field” due to a high 
magnetic flux density. This leads to increasing the “fringe field” on the surface of MSL gap 
that would be diverged into the FL surface resulting in the increase of magnetic field 
intensity on the FL (sensing layer) surface. 
As shown in Figs. 12-(b) and 12-(c), the BU1 and the leff are also strongly influenced by the 
MSL gap width. The BU1 is obviously re-developed when the MSL gap width is increased 
above 1.4 μm. Moreover, leff is sharply decreased when the MSL gap width is increased 
above 1.2 μm. The serious degradation of sensing performance relevant to the dramatic 
 
 
Fig. 12. Effects of MSL gap width on the sensing performance of an in-vitro GMR biosensor 
with an immobilized 250 nm size CoFe2O4 FNSA. (a) BU1, (b) Bmax, (c) leff, and (d) BU2 
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reduction  of “effective sensing area” on the sensor surface due to both the re-development 
of “undershoot field region” and the reduction of critical length, lc, are mainly attributed to 
the reduction of shield gap flux density, which is inversely proportional to the MSL gap 
width. However, considering that the lc (~1.56 μm), which is numerically determined based 
on the same geometry and configuration of in-vitro GMR biosensor system, is found to be 
much larger than that without MSL (~1.12 μm), it can be readily understood that shielding 
effects of MSL on the improvement of sensing performance is quite significant. 
In summary, it is numerically demonstrated that the MSL is effective to improve the output 
sensing performance of an in-vitro GMR biosensor with an immobilized FNSA, because it 
can successfully remove an undesirable “undershoot field region” and enhance the 
“effective sensing area” due to the increase of lc. This indicates that an in-vitro GMR 
biosensor with a specially designed MSL structure can be considered as a promising sensor 
structure for SMD due to its achievable high sensing signal and stability.   
5. Conclusion 
The physical sensing characteristics of an in-vitro GMR biosensor with an immobilized 
single FNSA have been introduced and discussed to explore its feasibility to a single 
molecular based disease diagnostic biosensor system. According to the theoretically and 
experimentally analyzed results, the in-vitro GMR biosensor with a FNSA was revealed to 
be more suitable for SMD than that with a SPNSA due to its higher relative MR, less 
interaction factor dependence, and practically allowable sensor size. In addition, the 
analytical models developed in this chapter allowed to readily predicting the optimized 
sensor geometry of an in-vitro GMR biosensor with a FNSA prior to fabrication if the 
physical parameters of the FNSA are provided. In particular, the in-vitro GMR biosensor 
with a specially designed magnetic shield layer (MSL) was demonstrated to be able to 
effectively control the undesirable “undershoot sensing region” as well as the “undetectable 
sensing area” on the FL surface. These promising sensing characteristics improved by the 
newly designed sensor structure allow for achieving both maximized output sensing signal 
and higher sensor stability that lead to accelerating the more practical applications to the 
SMD based diagnostic biosensor system.  
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